These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5526500)

  • 1. [Insulin-sensitivity and insulin-insensitivity in Indian diabetics as determined by the insulin tolerance test and their influence on the therapeutic response to tolbutamide].
    Singh I; Srivastava MC
    Acta Diabetol Lat; 1970; 7(5):767-76. PubMed ID: 5526500
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A; Catellier C
    Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution to the nutrition-dependent release of insulin in obese maturity-onset diabetics].
    Beringer A; Waldhäusl W
    Acta Diabetol Lat; 1968; 5(4):566-79. PubMed ID: 5720636
    [No Abstract]   [Full Text] [Related]  

  • 6. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE; Schneider SH
    Diabetologia; 1980 Jan; 18(1):49-54. PubMed ID: 6988265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. I. Body weight, carbohydrate metabolism and immunoreactive insulin].
    Appels A; Kattermann R; Proschek H; Hubrich K; Frerichs H; Söling HD; Creutzfeldt W
    Diabetologia; 1968 Aug; 4(4):210-20. PubMed ID: 4902712
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of tolbutamide treatment on serum insulin response measured by 3 methods].
    Aburaya K
    Nihon Naibunpi Gakkai Zasshi; 1971 Mar; 46(12):1206-25. PubMed ID: 5102334
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy of early diabetes. The University Group Diabetes Program.
    Prout TE
    Adv Metab Disord; 1973; 2():Suppl 2:501-20. PubMed ID: 4720381
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of propranolol on the hypoglycemic action of insulin and tolbutamide in diabetic patients].
    Kowalski S; Wolański A
    Pol Arch Med Wewn; 1969; 42(1):55-61. PubMed ID: 5767511
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modern aspects of pathogenesis in diabetes mellitus].
    Spanár E; Zahradny V; Uhrín P; Levcik A
    Z Gesamte Inn Med; 1974 Jun; 29(11):433-8. PubMed ID: 4849195
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies in subjects with positive postprandial Clinistix test. 3. Special studies and follow-up of cases with borderline glucose tolerance.
    Carlström S; Lundquist A; Lundquist I; Nordén A; Scherstén B; Wollmark G
    Acta Med Scand; 1971 May; 189(5):415-22. PubMed ID: 5578492
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes mellitus: therapeutic guidelines based on a functional classification.
    Karam JH
    Compr Ther; 1980 Aug; 6(8):50-5. PubMed ID: 6996904
    [No Abstract]   [Full Text] [Related]  

  • 16. [Various problems in diabetes: from the symposium of the 18th Congress of the Japanese Association of Medical Sciences].
    Yamada K; Abe M; Yamashita K; Murachi T; Shimada N
    Nihon Ishikai Zasshi; 1971 Aug; 66(3):247-60. PubMed ID: 4398768
    [No Abstract]   [Full Text] [Related]  

  • 17. Borderline diabetics and their response to tolbutamide.
    Keen H; Jarrett RJ; Ward JD; Fuller JH
    Adv Metab Disord; 1973; 2():Suppl 2:521-31. PubMed ID: 4720382
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of secondary failure to tolbutamide therapy.
    Jerums G; Ennis GC; Miller M
    Aust N Z J Med; 1974 Oct; 4(5):467-74. PubMed ID: 4616676
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics.
    Tan MH; Graham CA; Bradley RF; Gleason RE; Soeldner JS
    Diabetes; 1977 Jun; 26(6):561-70. PubMed ID: 324835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ethacrynic acid and carbohydrate metabolism in advanced age].
    Scotti G; Gatti A; Di Gregorio D
    G Gerontol; 1969 Nov; 17(11):1077-93. PubMed ID: 5397792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.